{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:08:52Z","timestamp":1773076132078,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Teva Pharmaceuticals, Israel","award":["101519"],"award-info":[{"award-number":["101519"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jneuroim.2014.08.624","type":"journal-article","created":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T20:38:20Z","timestamp":1409603900000},"page":"232-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Testing effects of glatiramer acetate and fingolimod in an infectious model of CNS immune surveillance"],"prefix":"10.1016","volume":"276","author":[{"given":"Cyd","family":"Castro-Rojas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krystin","family":"Deason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rehana Z.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liat","family":"Hayardeny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra C.","family":"Cravens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Yarovinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd N.","family":"Eagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamine","family":"Arellano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"St\u00fcve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2014.08.624_bb0050","doi-asserted-by":"crossref","first-page":"19045","DOI":"10.1073\/pnas.0509438102","article-title":"The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice","volume":"102","author":"Aharoni","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2014.08.624_bb0070","doi-asserted-by":"crossref","first-page":"21453","DOI":"10.1074\/jbc.C200176200","article-title":"The immune modulator FTY720 targets sphingosine 1-phosphate receptors","volume":"277","author":"Brinkmann","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2014.08.624_bb0065","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jneuroim.2014.08.624_bb0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1742-2094-8-73","article-title":"Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL\/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet","volume":"8","author":"Cravens","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2014.08.624_bb0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1742-2094-10-67","article-title":"The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis","volume":"10","author":"Cravens","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2014.08.624_bb0025","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1172\/JCI8970","article-title":"Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis","volume":"105","author":"Duda","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2014.08.624_bb0010","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4049\/jimmunol.146.1.286","article-title":"Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine","volume":"146","author":"Gazzinelli","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2014.08.624_bb0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4049\/jimmunol.149.1.175","article-title":"Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii","volume":"149","author":"Gazzinelli","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2014.08.624_bb0095","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1172\/JCI200214380","article-title":"Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis","volume":"109","author":"Karandikar","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2014.08.624_bb0020","first-page":"CD004678","article-title":"Glatiramer acetate for multiple sclerosis","author":"La Mantia","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jneuroim.2014.08.624_bb0030","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.1073\/pnas.97.13.7452","article-title":"Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells","volume":"97","author":"Neuhaus","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2014.08.624_bb0100","first-page":"S25","article-title":"The mechanism of action of glatiramer acetate treatment in multiple sclerosis","volume":"74","author":"Racke","year":"2010","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jneuroim.2014.08.624_bb0055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/cei.12206","article-title":"Requirement for safety monitoring for approved MS therapies\u2014an overview","volume":"175","author":"Rommer","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2014.08.624_bb0035","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/brain\/awh163","article-title":"Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo","volume":"127","author":"Weber","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2014.08.624_bb0040","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nm1620","article-title":"Type II monocytes modulate T cell-mediated central nervous system autoimmune disease","volume":"13","author":"Weber","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2014.08.624_bb0090","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.1109893","article-title":"TLR11 activation of dendritic cells by a protozoan profilin-like protein","volume":"308","author":"Yarovinsky","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2014.08.624_bb0015","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.immuni.2006.07.015","article-title":"Toll-like receptor recognition regulates immunodominance in an antimicrobial CD4+ T cell response","volume":"25","author":"Yarovinsky","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2014.08.624_bb0045","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/brain\/awf252","article-title":"Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor","volume":"125","author":"Ziemssen","year":"2002","journal-title":"Brain"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281400873X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281400873X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:26:54Z","timestamp":1759048014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557281400873X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":18,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S016557281400873X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2014.08.624","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testing effects of glatiramer acetate and fingolimod in an infectious model of CNS immune surveillance","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2014.08.624","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}